National Vaccine Advisory Committee
Executive Summary
Will meet June 14-15 to discuss new vaccine development and licensure, vaccine adverse events, testing, post-marketing surveillance, the 1990 National Vaccine Report to Congress and the National Vaccine Plan. Meeting begins at 9 a.m. on the first day and 8:30 a.m. on the second at HHS' Hubert Humphrey Building, Room 703A, 200 Independence Ave. S.W., Washington, D.C.
You may also be interested in...
Vaccination Health Next Stop For Dentovations’ Self+ Immunity Supplement Line
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
Balancing Innovation And Safety – The US and Australian Medtech Regulatory Systems Compared
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: